Funds and ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Hong Kong S.E.

Equities

2196

CNE100001M79

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:07 2024-06-03 EDT 5-day change 1st Jan Change
13.08 HKD +6.86% Intraday chart for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. +0.77% -23.06%

ETFs positioned on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Name Weight AuM 1st Jan change Investor Rating
2.37% 4 M€ -27.92%
0.63% 2 M€ -18.85% -
0.21% 3 M€ +0.10% -
0.18% 2 M€ -14.14%
0.16% 4 M€ -11.56%
0.03% 35 M€ -5.85% -
0.02% 454 M€ +4.02% -
0.02% 2,867 M€ +8.40% -
0.02% 153 M€ +3.74% -
0.02% 4 M€ -4.41% -
0.01% 32 M€ +6.87% -
0.01% 112 M€ +4.61% -
0.00% 34 M€ +7.50% -
0.00% 34 M€ +3.86% -
0.00% 39 M€ +5.00% -
0.00% 306 M€ +6.06% -
0.00% 7 M€ +0.11% -
0.00% 17 M€ +2.42% -
0.00% 15 M€ +16.31%
0.00% 7 M€ +5.36% -
0.00% 8 M€ +0.25% -
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities: - research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases; - sale of medical equipments and diagnosis products (17.3%); - medical and hospital services (10.5%); - other (0.1%). China accounts for 72.9% of net sales.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.17 CNY
Average target price
28.61 CNY
Spread / Average Target
+23.46%
Consensus
  1. Stock Market
  2. Equities
  3. 600196 Stock
  4. 2196 Stock
  5. Funds and ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.